Chapter 54
Outcomes Research and Pharmacoeconomics
Measuring value in health care
Outcomes Research and Pharmacoeconomics
Outcomes research studies health care interventions, care delivery processes, and quality to measure the extent to which optimal outcomes are reached. It evaluates effectiveness (real-world) versus efficacy (ideal trial conditions), uses observational studies, and supplements rather than replaces randomized controlled trials. Pharmacoeconomics, a division of health economics, balances the costs against the consequences (outcomes) of pharmaceutical therapies to inform decision-makers about value.
Outcomes are organized by the ECHO model into three domains that together capture the full value of an intervention.
The ECHO Model
Kozma and Reeder's ECHO model divides outcomes into Economic (acquisition/labor costs, cost of treating adverse reactions, readmissions), Clinical (length of stay, adverse drug reactions, death), and Humanistic (patient satisfaction, functional status, quality of life). Pharmacoeconomics balances COSTS against CONSEQUENCES.
📖 “Outcomes research: studies interventions/processes/quality; effectiveness (real-world) vs efficacy (ideal); observational; supplements RCTs. Pharmacoeconomics: balances costs vs consequences/outcomes for decision-makers. ECHO model (Kozma & Reeder): Economic, Clinical, Humanistic outcomes.”